|
Avaliação DCF da ABVC Biopharma, Inc. (ABVC) |
Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
Design Profissional: Modelos Confiáveis E Padrão Da Indústria
Pré-Construídos Para Uso Rápido E Eficiente
Compatível com MAC/PC, totalmente desbloqueado
Não É Necessária Experiência; Fácil De Seguir
ABVC BioPharma, Inc. (ABVC) Bundle
Aprimore suas estratégias de investimento com a calculadora ABVC DCF! Explore os dados financeiros autênticos da ABVC Biopharma, Inc., ajustam as projeções e despesas de crescimento e observe instantaneamente como essas modificações afetam o valor intrínseco da ABVC.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | .7 | .5 | .4 | 1.0 | .2 | .1 | .1 | .1 | .1 | .1 |
| Revenue Growth, % | 0 | -31.16 | -26.34 | 172.57 | -84.28 | -10.45 | -10.45 | -10.45 | -10.45 | -10.45 |
| EBITDA | -3.5 | -10.4 | -11.0 | -15.2 | -8.1 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBITDA, % | -494.95 | -2147.16 | -3083.68 | -1567.03 | -5335.18 | -100 | -100 | -100 | -100 | -100 |
| Depreciation | .1 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Depreciation, % | 7.85 | 7.69 | 3.37 | 2.45 | 18.72 | 8.02 | 8.02 | 8.02 | 8.02 | 8.02 |
| EBIT | -3.5 | -10.4 | -11.0 | -15.2 | -8.2 | -.1 | -.1 | -.1 | -.1 | -.1 |
| EBIT, % | -502.8 | -2154.85 | -3087.05 | -1569.49 | -5353.9 | -100 | -100 | -100 | -100 | -100 |
| Total Cash | .1 | 4.3 | 5.9 | .2 | .1 | .1 | .1 | .1 | .1 | .1 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | .6 | 1.0 | 1.7 | 1.4 | .8 | .1 | .1 | .1 | .1 | .1 |
| Account Receivables, % | 91.28 | 206.9 | 481.37 | 141.22 | 498.3 | 98.26 | 98.26 | 98.26 | 98.26 | 98.26 |
| Inventories | -.5 | -.8 | .0 | 1.3 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | -67.97 | -173.83 | 7.3 | 134.72 | 0 | -12.13 | -12.13 | -12.13 | -12.13 | -12.13 |
| Accounts Payable | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Accounts Payable, % | 3.42 | 4.77 | 0 | 0 | 0 | 1.64 | 1.64 | 1.64 | 1.64 | 1.64 |
| Capital Expenditure | .0 | .0 | .0 | -.1 | .0 | .0 | .0 | .0 | .0 | .0 |
| Capital Expenditure, % | 0 | 0 | -4.92 | -12.34 | -13.91 | -6.23 | -6.23 | -6.23 | -6.23 | -6.23 |
| Tax Rate, % | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 |
| EBITAT | -3.5 | -10.2 | -11.8 | -16.0 | -8.1 | -.1 | -.1 | -.1 | -.1 | -.1 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3.5 | -10.2 | -13.4 | -17.0 | -6.1 | .5 | -.1 | -.1 | -.1 | -.1 |
| WACC, % | 42.8 | 42.75 | 43.56 | 43.56 | 43.04 | 43.14 | 43.14 | 43.14 | 43.14 | 43.14 |
| PV UFCF | ||||||||||
| SUM PV UFCF | .2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | 0 | |||||||||
| Terminal Value | 0 | |||||||||
| Present Terminal Value | 0 | |||||||||
| Enterprise Value | 0 | |||||||||
| Net Debt | 2 | |||||||||
| Equity Value | -2 | |||||||||
| Diluted Shares Outstanding, MM | 4 | |||||||||
| Equity Value Per Share | -0.46 |
What You Will Receive
- Customizable Excel Template: An adaptable Excel-based DCF Calculator featuring pre-filled real ABVC financials.
- Actual Data: Historical performance data and future estimates (highlighted in the yellow cells).
- Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA %, and WACC.
- Instant Calculations: Quickly observe how your inputs affect ABVC’s valuation.
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- User-Centric Layout: Organized for clarity and simplicity, complete with step-by-step guidance.
Key Features
- Customizable Research Parameters: Adjust essential variables such as clinical trial timelines, market penetration rates, and R&D expenditures.
- Instant DCF Valuation: Quickly computes intrinsic value, NPV, and other key metrics with ease.
- High-Precision Accuracy: Leverages ABVC's actual financial data for dependable valuation results.
- Effortless Scenario Analysis: Evaluate various hypotheses and analyze results without hassle.
- Efficiency Booster: Remove the complexity of creating intricate valuation models from the ground up.
How It Works
- Step 1: Download the Excel file for ABVC BioPharma, Inc. (ABVC).
- Step 2: Review ABVC's pre-filled financial data and projections.
- Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model refresh in real-time as you modify assumptions.
- Step 5: Evaluate the outputs and leverage the findings for investment strategies.
Why Choose This Calculator for ABVC BioPharma, Inc. (ABVC)?
- Accurate Data: Utilize real ABVC financials for dependable valuation outcomes.
- Customizable: Tailor essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Built-in calculations save you from starting from square one.
- Professional-Grade Tool: Crafted for investors, analysts, and consultants in the biotech sector.
- User-Friendly: An intuitive design and clear instructions make it accessible for users of all levels.
Who Should Use This Product?
- Biotech Students: Explore drug development processes and apply theoretical knowledge with real-world data.
- Researchers: Utilize advanced models for analyzing clinical trial results in coursework or studies.
- Investors: Evaluate your investment strategies and assess valuation projections for ABVC BioPharma, Inc. (ABVC).
- Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
- Healthcare Entrepreneurs: Understand the valuation methods used for public biotech firms like ABVC BioPharma, Inc. (ABVC).
What the Template Contains
- Comprehensive DCF Model: Editable template featuring detailed valuation calculations tailored for ABVC BioPharma, Inc. (ABVC).
- Real-World Data: ABVC’s historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into ABVC's performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to ABVC.
- Dashboard with Visual Outputs: Charts and tables designed to provide clear, actionable results for ABVC BioPharma, Inc. (ABVC).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.